category,subcategory,ID,Description,GeneRatio,BgRatio,RichFactor,FoldEnrichment,zScore,pvalue,p.adjust,qvalue,geneID,Count
Human Diseases,Infectious disease: viral,hsa05169,Epstein-Barr virus infection,16/175,71/2914,0.22535211267605634,3.752434607645875,5.934047315108284,2.527429375726152e-6,3.8997795598272013e-4,3.196683804919946e-4,OAS1/ICAM1/BLNK/GADD45B/JAK3/OAS3/OAS2/GADD45A/CR2/CDK2/CDKN1A/IL6/MYC/TLR2/B2M/ISG15,16
Organismal Systems,Immune system,hsa04640,Hematopoietic cell lineage,13/175,49/2914,0.2653061224489796,4.417725947521866,6.097702235903324,3.3189613275125116e-6,3.8997795598272013e-4,3.196683804919946e-4,IL4R/IL1R2/IL1R1/CR2/IL1B/CD36/IL6/FCGR1A/CD1D/CD14/CD34/CD8B2/ITGB3,13
Environmental Information Processing,Signaling molecules and interaction,hsa04061,Viral protein interaction with cytokine and cytokine receptor,11/175,37/2914,0.2972972972972973,4.950424710424711,6.111783628343511,5.823446948934989e-6,4.5617001099990746e-4,3.7392659356319405e-4,CXCL12/CCL2/IL18RAP/TNFRSF10B/TNFSF10/IL6/CXCR1/CCR1/CX3CR1/TNFRSF10D/CXCR2,11
Environmental Information Processing,Signal transduction,hsa04064,NF-kappa B signaling pathway,12/175,47/2914,0.2553191489361702,4.251428571428571,5.679401224339607,1.242495305375857e-5,6.240963021799144e-4,5.115772600175783e-4,ICAM1/BLNK/GADD45B/CARD10/CXCL12/IL1R1/GADD45A/IL1B/BCL2A1/TNFRSF13C/CD14/CARD11,12
Environmental Information Processing,Signaling molecules and interaction,hsa04060,Cytokine-cytokine receptor interaction,21/175,127/2914,0.16535433070866143,2.7533858267716536,5.1062740378754965,1.3278644727232223e-5,6.240963021799144e-4,5.115772600175783e-4,IL4R/CXCL12/CCL2/IL1R2/IL1R1/IL1RL1/IL18RAP/TNFRSF10B/TNFSF10/IL1B/LIF/IL6/OSMR/TNFRSF13C/INHBB/CXCR1/CCR1/CX3CR1/TNFRSF10D/CXCR2/RELL1,21
Human Diseases,Infectious disease: viral,hsa05168,Herpes simplex virus 1 infection,11/175,49/2914,0.22448979591836735,3.738075801749271,4.885111092802886,1.051003920975977e-4,0.0041164320238225765,0.0033742757462912948,OAS1/CCL2/OAS3/OAS2/IL1B/IL6/TLR2/TLR3/B2M/SOCS3/ITGB3,11
Cellular Processes,Cell growth and death,hsa04115,p53 signaling pathway,8/175,31/2914,0.25806451612903225,4.297142857142857,4.664332917799211,3.4497032544700306e-4,0.010898015269264988,0.008933199526429979,GADD45B/TP53I3/GADD45A/TNFRSF10B/CDK2/CDKN1A/THBS1/CCNB2,8
Human Diseases,Infectious disease: viral,hsa05164,Influenza A,11/175,56/2914,0.19642857142857142,3.2708163265306123,4.336488108679415,3.709962644856166e-4,0.010898015269264988,0.008933199526429979,OAS1/ICAM1/CCL2/OAS3/OAS2/TNFRSF10B/TNFSF10/IL1B/IL6/TLR3/SOCS3,11
Human Diseases,Infectious disease: parasitic,hsa05144,Malaria,8/175,32/2914,0.25,4.162857142857143,4.546747408945462,4.3670506700814866e-4,0.011402854527434992,0.009347020732455113,ICAM1/CCL2/IL1B/CD36/IL6/TLR2/THBS1/ACKR1,8
Organismal Systems,Immune system,hsa04613,Neutrophil extracellular trap formation,14/175,88/2914,0.1590909090909091,2.649090909090909,3.970023755027873,5.996898516957799e-4,0.014092711514850828,0.01155192030108713,TLR8/SELPLG/NCF2/RAC2/SIGLEC9/TLR2/FCGR2A/FCGR1A/FPR2/FPR1/CASP4/FCGR3A/ITGB3/H4C2,14
Human Diseases,Endocrine and metabolic disease,hsa04933,AGE-RAGE signaling pathway in diabetic complications,10/175,52/2914,0.19230769230769232,3.202197802197803,4.04964013954089,8.210007284957069e-4,0.017539561017862828,0.014377333331551615,EDN1/ICAM1/CCL2/VEGFA/F3/IL1B/IL6/PIM1/COL3A1/THBD,10
Environmental Information Processing,Signal transduction,hsa04068,FoxO signaling pathway,10/175,55/2914,0.18181818181818182,3.0275324675324677,3.8365011704709135,0.0012967919065230234,0.025395508169409206,0.02081692270997485,GADD45B/BCL6/GADD45A/TNFSF10/CDK2/CDKN1A/IL6/PLK4/CCNB2/DEPP1,10
Cellular Processes,Transport and catabolism,hsa04145,Phagosome,11/175,66/2914,0.16666666666666666,2.775238095238095,3.686819151183256,0.001579150566571378,0.026507170224590985,0.021728161931019715,NCF2/CD36/TLR2/THBS1/FCGR2A/FCGR1A/CD14/TUBB6/SFTPA2/FCGR3A/ITGB3,11
Human Diseases,Cardiovascular disease,hsa05418,Fluid shear stress and atherosclerosis,11/175,66/2914,0.16666666666666666,2.775238095238095,3.686819151183256,0.001579150566571378,0.026507170224590985,0.021728161931019715,EDN1/ICAM1/CCL2/VEGFA/IL1R2/IL1R1/NCF2/IL1B/RAC2/THBD/ITGB3,11
Organismal Systems,Immune system,hsa04621,NOD-like receptor signaling pathway,12/175,78/2914,0.15384615384615385,2.5617582417582416,3.5334686714774586,0.0019968175152180485,0.03128347440508276,0.025643340721747572,OAS1/NLRP1/NAMPT/CCL2/OAS3/OAS2/IL1B/IL6/GBP4/IFI16/CASP4/CASP12,12
Environmental Information Processing,Signal transduction,hsa04630,JAK-STAT signaling pathway,10/175,59/2914,0.1694915254237288,2.82227602905569,3.5738009701210784,0.0022588045969472877,0.033091427977327566,0.02712533625913078,IL4R/JAK3/CISH/CDKN1A/LIF/IL6/MYC/PIM1/OSMR/SOCS3,10
Human Diseases,Infectious disease: bacterial,hsa05130,Pathogenic Escherichia coli infection,12/175,80/2914,0.15,2.4977142857142853,3.4329485395504156,0.0024922069898948777,0.033091427977327566,0.02712533625913078,TJP1/CLDN16/IL1R1/TNFRSF10B/TNFSF10/IL1B/IL6/MYO1G/FCGR2A/LPAR4/TUBB6/CASP4,12
Environmental Information Processing,Signal transduction,hsa04151,PI3K-Akt signaling pathway,20/175,171/2914,0.11695906432748537,1.9475355054302421,3.2275568040988776,0.002534662568476154,0.033091427977327566,0.02712533625913078,IL4R/FGF20/ANGPT2/JAK3/VEGFA/SPP1/NR4A1/CDK2/CDKN1A/IL6/MYC/TLR2/THBS1/FGF2/EPHA2/OSMR/LPAR4/PIK3AP1/EFNA1/ITGB3,20
Human Diseases,Infectious disease: viral,hsa05163,Human cytomegalovirus infection,13/175,95/2914,0.1368421052631579,2.2786165413533834,3.202195433078142,0.0038302383642379004,0.04583375573892601,0.037570335051392886,CXCL12/CCL2/VEGFA/IL1R1/CDKN1A/IL1B/RAC2/IL6/MYC/CCR1/B2M/CXCR2/ITGB3,13
Human Diseases,Infectious disease: bacterial,hsa05150,Staphylococcus aureus infection,7/175,35/2914,0.2,3.3302857142857145,3.5052226796491808,0.004002317989456402,0.04583375573892601,0.037570335051392886,ICAM1/SELPLG/FCGR2A/FCGR1A/FPR2/FPR1/FCGR3A,7
Human Diseases,Infectious disease: viral,hsa05166,Human T-cell leukemia virus 1 infection,12/175,85/2914,0.1411764705882353,2.3507899159663865,3.1942878494857827,0.004180093390216606,0.04583375573892601,0.037570335051392886,ICAM1/JAK3/IL1R2/IL1R1/CDK2/CDKN1A/ZFP36/IL6/MYC/CCNB2/TNFRSF13C/B2M,12
Human Diseases,Cancer: specific types,hsa05221,Acute myeloid leukemia,6/175,27/2914,0.2222222222222222,3.7003174603174602,3.562595912268995,0.00441955999543932,0.04583375573892601,0.037570335051392886,MYC/PIM1/BCL2A1/FCGR1A/RUNX1/CD14,6
Human Diseases,Cancer: overview,hsa05202,Transcriptional misregulation in cancer,11/175,75/2914,0.14666666666666667,2.442209523809524,3.1979343587694835,0.004485856944660843,0.04583375573892601,0.037570335051392886,GADD45B/BCL6/IL1R2/GADD45A/CDKN1A/IL6/MYC/BCL2A1/FCGR1A/RUNX1/CD14,11
Human Diseases,Infectious disease: viral,hsa05160,Hepatitis C,9/175,57/2914,0.15789473684210525,2.629172932330827,3.139371737116136,0.006075338279037082,0.05948768731557143,0.04876258355542922,OAS1/OAS3/OAS2/CLDN16/CDK2/CDKN1A/MYC/TLR3/SOCS3,9
Human Diseases,Infectious disease: viral,hsa05167,Kaposi sarcoma-associated herpesvirus infection,11/175,79/2914,0.13924050632911392,2.3185533453887883,3.0028108022567035,0.006709180922592076,0.062003732702567864,0.050825008217558434,ICAM1/ANGPT2/HCK/VEGFA/CDKN1A/ZFP36/IL6/MYC/FGF2/CCR1/TLR3,11
Human Diseases,Infectious disease: parasitic,hsa05146,Amoebiasis,8/175,48/2914,0.16666666666666666,2.775238095238095,3.134240983245206,0.006859987447943678,0.062003732702567864,0.050825008217558434,IL1R2/IL1R1/IL1B/IL6/TLR2/CD1D/COL3A1/CD14,8
Organismal Systems,Immune system,hsa04610,Complement and coagulation cascades,7/175,40/2914,0.175,2.914,3.0805041466813763,0.008607461462500028,0.0749167942106484,0.061409958972222435,PLAUR/CR2/F3/F2RL3/KLKB1/THBD/SERPINA1,7
Human Diseases,Cancer: specific types,hsa05216,Thyroid cancer,4/175,15/2914,0.26666666666666666,4.440380952380952,3.3761466815804053,0.010171285669832617,0.08044686561495622,0.06594300742457777,GADD45B/GADD45A/CDKN1A/MYC,4
Human Diseases,Immune disease,hsa05340,Primary immunodeficiency,4/175,15/2914,0.26666666666666666,4.440380952380952,3.3761466815804053,0.010171285669832617,0.08044686561495622,0.06594300742457777,BLNK/JAK3/TNFRSF13C/CD8B2,4
Environmental Information Processing,Signal transduction,hsa04015,Rap1 signaling pathway,13/175,107/2914,0.12149532710280374,2.0230707610146865,2.7250194468259368,0.010544206290215618,0.08044686561495622,0.06594300742457777,FGF20/ANGPT2/VEGFA/ARAP3/F2RL3/RAC2/THBS1/FGF2/EPHA2/LPAR4/EFNA1/FPR1/ITGB3,13
Human Diseases,Infectious disease: viral,hsa05171,Coronavirus disease - COVID-19,11/175,84/2914,0.13095238095238096,2.180544217687075,2.774737695258577,0.010612139719419756,0.08044686561495622,0.06594300742457777,OAS1/TLR8/CCL2/OAS3/OAS2/IL1B/IL6/TLR2/FCGR2A/TLR3/ISG15,11
Human Diseases,Infectious disease: viral,hsa05162,Measles,8/175,52/2914,0.15384615384615385,2.5617582417582416,2.8719304223131306,0.011144196607265032,0.08184019383460257,0.0670851308924178,OAS1/JAK3/OAS3/OAS2/CDK2/IL1B/IL6/TLR2,8
Organismal Systems,Development and regeneration,hsa04380,Osteoclast differentiation,9/175,65/2914,0.13846153846153847,2.3055824175824173,2.6903451305958805,0.014274714330702565,0.10062237565428693,0.08248105148817252,BLNK/IL1R1/NCF2/IL1B/FCGR2A/FCGR1A/SOCS3/FCGR3A/ITGB3,9
Human Diseases,Immune disease,hsa05321,Inflammatory bowel disease,5/175,25/2914,0.2,3.3302857142857145,2.9573222902211866,0.014665138831199352,0.10062237565428693,0.08248105148817252,IL4R/IL18RAP/IL1B/IL6/TLR2,5
Organismal Systems,Immune system,hsa04659,Th17 cell differentiation,6/175,35/2914,0.17142857142857143,2.854530612244898,2.7895904447652944,0.016260683771182404,0.10062237565428693,0.08248105148817252,IL4R/JAK3/IL1R1/IL1B/IL6/RUNX1,6
Organismal Systems,Immune system,hsa04662,B cell receptor signaling pathway,6/175,35/2914,0.17142857142857143,2.854530612244898,2.7895904447652944,0.016260683771182404,0.10062237565428693,0.08248105148817252,DAPP1/BLNK/CR2/RAC2/PIK3AP1/CARD11,6
Organismal Systems,Immune system,hsa04620,Toll-like receptor signaling pathway,7/175,45/2914,0.15555555555555556,2.590222222222222,2.717015096048236,0.016270852233459164,0.10062237565428693,0.08248105148817252,TLR8/SPP1/IL1B/IL6/TLR2/TLR3/CD14,7
Human Diseases,Immune disease,hsa05323,Rheumatoid arthritis,7/175,45/2914,0.15555555555555556,2.590222222222222,2.717015096048236,0.016270852233459164,0.10062237565428693,0.08248105148817252,ICAM1/CXCL12/CCL2/VEGFA/IL1B/IL6/TLR2,7
Human Diseases,Cancer: specific types,hsa05219,Bladder cancer,4/175,18/2914,0.2222222222222222,3.7003174603174602,2.904323901288209,0.019801644706799973,0.11880929443101085,0.0973890297015677,VEGFA/CDKN1A/MYC/THBS1,4
Human Diseases,Cancer: specific types,hsa05220,Chronic myeloid leukemia,5/175,27/2914,0.18518518518518517,3.083597883597883,2.7489424528793993,0.020222858626555037,0.11880929443101085,0.0973890297015677,GADD45B/GADD45A/CDKN1A/MYC/RUNX1,5
Human Diseases,Drug resistance: antineoplastic,hsa01523,Antifolate resistance,3/175,11/2914,0.2727272727272727,4.541298701298701,2.9739155746907824,0.024560937388928096,0.1407761045462952,0.11539541828430917,ABCG2/IL1B/IL6,3
Environmental Information Processing,Signal transduction,hsa04668,TNF signaling pathway,8/175,63/2914,0.12698412698412698,2.114467120181406,2.260123530043902,0.03274084584839758,0.1817071374166283,0.1489469480279641,EDN1/ICAM1/CCL2/IRF1/IL1B/LIF/IL6/SOCS3,8
Human Diseases,Infectious disease: parasitic,hsa05140,Leishmaniasis,6/175,41/2914,0.14634146341463414,2.436794425087108,2.3415961755743115,0.033480312155814415,0.1817071374166283,0.1489469480279641,NCF2/IL1B/TLR2/FCGR2A/FCGR1A/FCGR3A,6
Human Diseases,Cancer: specific types,hsa05212,Pancreatic cancer,5/175,31/2914,0.16129032258064516,2.6857142857142855,2.384710937176373,0.03508896581420718,0.1817071374166283,0.1489469480279641,GADD45B/VEGFA/GADD45A/CDKN1A/RAC2,5
Human Diseases,Cancer: specific types,hsa05218,Melanoma,5/175,31/2914,0.16129032258064516,2.6857142857142855,2.384710937176373,0.03508896581420718,0.1817071374166283,0.1489469480279641,FGF20/GADD45B/GADD45A/CDKN1A/FGF2,5
Human Diseases,Infectious disease: viral,hsa05161,Hepatitis B,8/175,64/2914,0.125,2.0814285714285714,2.210846788264562,0.03556820562197831,0.1817071374166283,0.1489469480279641,JAK3/CDK2/CDKN1A/IL6/MYC/TLR2/TLR3/CASP12,8
Cellular Processes,Cell growth and death,hsa04218,Cellular senescence,7/175,53/2914,0.1320754716981132,2.199245283018868,2.22679519423703,0.036978065291112444,0.18489032645556222,0.15155623624352918,GADD45B/GADD45A/CDK2/CDKN1A/IL6/MYC/CCNB2,7
Organismal Systems,Circulatory system,hsa04270,Vascular smooth muscle contraction,8/175,65/2914,0.12307692307692308,2.0494065934065935,2.1624570617415,0.03855676580320996,0.18876749924488206,0.15473438907867157,EDN1/MYLK2/ACTA2/CALCA/EDN3/PLA2G5/RAMP2/ADM,8
Human Diseases,Cancer: specific types,hsa05226,Gastric cancer,8/175,66/2914,0.12121212121212122,2.0183549783549783,2.114922300829958,0.04170969118776187,0.2000362740637559,0.1639715034878716,FGF20/GADD45B/GADD45A/CDK2/CDKN1A/MYC/FGF2/WNT7A,8
Cellular Processes,Cell growth and death,hsa04210,Apoptosis,7/175,55/2914,0.12727272727272726,2.119272727272727,2.1178901926458185,0.04405189949893452,0.20704392764499224,0.16971573912221088,GADD45B/LMNB1/GADD45A/TNFRSF10B/TNFSF10/BCL2A1/CASP12,7
Organismal Systems,Immune system,hsa04650,Natural killer cell mediated cytotoxicity,7/175,56/2914,0.125,2.0814285714285714,2.0651613631609793,0.04789555032287636,0.22069518286031262,0.18090579378919247,ICAM1/ICAM2/TNFRSF10B/TNFSF10/RAC2/FCER1G/FCGR3A,7
Human Diseases,Cardiovascular disease,hsa05417,Lipid and atherosclerosis,10/175,93/2914,0.10752688172043011,1.7904761904761903,1.958041873092892,0.04969207711090013,0.22456996386656788,0.18408198605859766,ICAM1/CCL2/NCF2/TNFRSF10B/TNFSF10/IL1B/CD36/IL6/TLR2/CD14,10
Organismal Systems,Immune system,hsa04062,Chemokine signaling pathway,9/175,82/2914,0.10975609756097561,1.827595818815331,1.921196735735287,0.05474246846451568,0.24272603941813553,0.19896468180747506,HCK/JAK3/CXCL12/CCL2/RAC2/CXCR1/CCR1/CX3CR1/CXCR2,9
Cellular Processes,Cell growth and death,hsa04217,Necroptosis,7/175,58/2914,0.1206896551724138,2.0096551724137934,1.9629137637035816,0.0562096212787587,0.24461594445385731,0.20051385368446087,PYGL/JAK3/TNFRSF10B/TNFSF10/IL1B/SPATA2L/TLR3,7
Organismal Systems,Digestive system,hsa04978,Mineral absorption,4/175,25/2914,0.16,2.6642285714285716,2.112041549298721,0.05911828339924407,0.2525963017967701,0.20705542319735246,MT2A/MT1X/MT1A/MT1M,4
Human Diseases,Cancer: specific types,hsa05222,Small cell lung cancer,5/175,36/2914,0.1388888888888889,2.312698412698413,2.002922135426829,0.06127465704189123,0.25713472151507927,0.21077560598996423,GADD45B/GADD45A/CDK2/CDKN1A/MYC,5
Organismal Systems,Immune system,hsa04657,IL-17 signaling pathway,5/175,37/2914,0.13513513513513514,2.2501930501930505,1.9341994789257095,0.06755334623144935,0.2785094099015894,0.22829662715337454,CCL2/IL1B/IL6/S100A8/S100A9,5
Environmental Information Processing,Signal transduction,hsa04066,HIF-1 signaling pathway,6/175,49/2914,0.12244897959183673,2.038950437317784,1.8536332350517868,0.07037060600344462,0.28512228294499115,0.23371725768839144,EDN1/ANGPT2/VEGFA/CDKN1A/IL6/PDK1,6
Human Diseases,Cancer: specific types,hsa05210,Colorectal cancer,5/175,38/2914,0.13157894736842105,2.190977443609022,1.8676442034338123,0.07417711499875679,0.28819911383400576,0.2362393631875613,GADD45B/GADD45A/CDKN1A/RAC2/MYC,5
Human Diseases,Infectious disease: bacterial,hsa05134,Legionellosis,4/175,27/2914,0.14814814814814814,2.4668783068783067,1.9352889934898034,0.07480913167606107,0.28819911383400576,0.2362393631875613,IL1B/IL6/TLR2/CD14,4
Human Diseases,Cancer: specific types,hsa05213,Endometrial cancer,4/175,27/2914,0.14814814814814814,2.4668783068783067,1.9352889934898034,0.07480913167606107,0.28819911383400576,0.2362393631875613,GADD45B/GADD45A/CDKN1A/MYC,4
Cellular Processes,Cell growth and death,hsa04110,Cell cycle,6/175,50/2914,0.12,1.9981714285714287,1.7992722438546767,0.07616914684821603,0.28870563724727044,0.23665456491041656,GADD45B/GADD45A/CDK2/CDKN1A/MYC/CCNB2,6
Environmental Information Processing,Signal transduction,hsa04010,MAPK signaling pathway,14/175,155/2914,0.09032258064516129,1.504,1.6297229666281488,0.07823431208016285,0.2918264022037821,0.23921268355338016,FGF20/ANGPT2/GADD45B/VEGFA/IL1R1/GADD45A/NR4A1/IL1B/RAC2/MYC/FGF2/EPHA2/EFNA1/CD14,14
Human Diseases,Endocrine and metabolic disease,hsa04931,Insulin resistance,5/175,39/2914,0.1282051282051282,2.1347985347985343,1.8031231776591419,0.08114255816742144,0.2979453307710006,0.24422842343154813,PYGL/CD36/IL6/PPP1R3B/SOCS3,5
Organismal Systems,Digestive system,hsa04979,Cholesterol metabolism,4/175,29/2914,0.13793103448275862,2.296748768472906,1.7736796569284374,0.09238590371000349,0.3302100570902482,0.2706761050280646,LIPG/CD36/ANGPTL4/LCAT,4
Human Diseases,Cancer: overview,hsa05205,Proteoglycans in cancer,9/175,91/2914,0.0989010989010989,1.6468445839874408,1.5843767247318128,0.09273984582109099,0.3302100570902482,0.2706761050280646,PLAUR/VEGFA/CDKN1A/MYC/TLR2/THBS1/FGF2/WNT7A/ITGB3,9
Organismal Systems,Immune system,hsa04670,Leukocyte transendothelial migration,6/175,53/2914,0.11320754716981132,1.885067385444744,1.6434200979494542,0.09514114361310144,0.3337040111802812,0.27354013010522493,ICAM1/CXCL12/CLDN16/NCF2/RAC2/F11R,6
Human Diseases,Infectious disease: parasitic,hsa05143,African trypanosomiasis,3/175,19/2914,0.15789473684210525,2.629172932330827,1.8005822016346877,0.10166775788557302,0.34979057967206717,0.2867264326091301,ICAM1/IL1B/IL6,3
Human Diseases,Infectious disease: bacterial,hsa05133,Pertussis,5/175,42/2914,0.11904761904761904,1.9823129251700677,1.620598887463447,0.10403785844964397,0.34979057967206717,0.2867264326091301,IRF1/IL1B/IL6/CD14/SFTPA2,5
Human Diseases,Infectious disease: bacterial,hsa05152,Tuberculosis,8/175,80/2914,0.1,1.6651428571428573,1.5245906524367354,0.10419293862572214,0.34979057967206717,0.2867264326091301,IL1B/IL6/TLR2/FCGR2A/FCGR1A/FCER1G/CD14/FCGR3A,8
Human Diseases,Immune disease,hsa05332,Graft-versus-host disease,2/175,10/2914,0.2,3.3302857142857145,1.8655380750054764,0.11750805661928634,0.38893511697932803,0.31881355613535073,IL1B/IL6,2
Organismal Systems,Immune system,hsa04666,Fc gamma R-mediated phagocytosis,5/175,44/2914,0.11363636363636363,1.8922077922077922,1.5071089617305784,0.12089801637569739,0.39459769233734565,0.3234552192507693,HCK/RAC2/FCGR2A/FCGR1A/FCGR3A,5
Human Diseases,Infectious disease: bacterial,hsa05132,Salmonella infection,9/175,98/2914,0.09183673469387756,1.5292128279883384,1.3468533969742822,0.13088879780847296,0.4158888962300024,0.34090780743601545,TNFRSF10B/TNFSF10/IL1B/IL6/MYC/TLR2/CD14/TUBB6/CASP4,9
Human Diseases,Cancer: specific types,hsa05223,Non-small cell lung cancer,4/175,33/2914,0.12121212121212122,2.0183549783549783,1.4868863761178814,0.1327304987968093,0.4158888962300024,0.34090780743601545,GADD45B/JAK3/GADD45A/CDKN1A,4
Human Diseases,Cancer: overview,hsa05230,Central carbon metabolism in cancer,4/175,33/2914,0.12121212121212122,2.0183549783549783,1.4868863761178814,0.1327304987968093,0.4158888962300024,0.34090780743601545,SLC1A5/MYC/SLC16A3/PDK1,4
Human Diseases,Infectious disease: bacterial,hsa05120,Epithelial cell signaling in Helicobacter pylori infection,4/175,34/2914,0.11764705882352941,1.9589915966386553,1.4215144107821418,0.14379322981734968,0.44462380272469965,0.36446206449549856,TJP1/F11R/CXCR1/CXCR2,4
Cellular Processes,Cellular community - eukaryotes,hsa04530,Tight junction,6/175,60/2914,0.1,1.6651428571428573,1.315699843282723,0.14815601778103643,0.4521644698512151,0.3706432160482525,YBX3/TJP1/CLDN16/CD1D/F11R/RUNX1,6
Human Diseases,Cancer: specific types,hsa05224,Breast cancer,7/175,74/2914,0.0945945945945946,1.575135135135135,1.2665427111580665,0.15305318695184184,0.4601659818737542,0.37720212623918037,FGF20/GADD45B/GADD45A/CDKN1A/MYC/FGF2/WNT7A,7
Environmental Information Processing,Signaling molecules and interaction,hsa04514,Cell adhesion molecules,8/175,88/2914,0.09090909090909091,1.5137662337662339,1.2368415478729142,0.15533263774505288,0.4601659818737542,0.37720212623918037,CDH3/ICAM1/ICAM2/SELPLG/CLDN16/F11R/CD34/CD8B2,8
Organismal Systems,Immune system,hsa04611,Platelet activation,6/175,61/2914,0.09836065573770492,1.6378454332552692,1.272397281880558,0.15665224914851206,0.4601659818737542,0.37720212623918037,MYLK2/F2RL3/FCGR2A/FCER1G/COL3A1/ITGB3,6
Human Diseases,Cancer: overview,hsa05200,Pathways in cancer,19/175,249/2914,0.07630522088353414,1.2705909351692486,1.1283856669116974,0.16072712205846848,0.4663070825153098,0.3822360407628296,IL4R/EDN1/FGF20/GADD45B/JAK3/CXCL12/VEGFA/GADD45A/CDK2/CDKN1A/F2RL3/RAC2/IL6/MYC/PIM1/FGF2/LPAR4/WNT7A/RUNX1,19
Human Diseases,Cancer: specific types,hsa05217,Basal cell carcinoma,4/175,37/2914,0.10810810810810811,1.8001544401544403,1.2379354540227425,0.17899535057965815,0.512974480319752,0.4204897195902111,GADD45B/GADD45A/CDKN1A/WNT7A,4
Organismal Systems,Immune system,hsa04672,Intestinal immune network for IgA production,3/175,25/2914,0.12,1.9981714285714287,1.2667608083762552,0.18683884041398574,0.5290015361118874,0.4336272390077286,CXCL12/IL6/TNFRSF13C,3
Cellular Processes,Cellular community - eukaryotes,hsa04550,Signaling pathways regulating pluripotency of stem cells,6/175,65/2914,0.09230769230769231,1.537054945054945,1.1066809240327409,0.19266104015052254,0.5389921956592,0.44181667102187505,JAK3/LIF/MYC/FGF2/WNT7A/INHBB,6
Human Diseases,Infectious disease: bacterial,hsa05135,Yersinia infection,6/175,66/2914,0.09090909090909091,1.5137662337662339,1.0669910672610925,0.20212766884124067,0.5588235550316654,0.4580726117392823,CCL2/IL1B/RAC2/IL6/FCGR2A/CD8B2,6
Human Diseases,Cancer: overview,hsa05206,MicroRNAs in cancer,7/175,81/2914,0.08641975308641975,1.4390123456790123,1.0127195785644836,0.210712370057205,0.575783801900502,0.4719750761379256,VEGFA/CDKN1A/MYC/PIM1/THBS1/EFNA1/ITGB3,7
Organismal Systems,Immune system,hsa04623,Cytosolic DNA-sensing pathway,3/175,27/2914,0.1111111111111111,1.8501587301587301,1.121635534100208,0.2184683541590632,0.5901156692802283,0.48372303461716365,IL1B/IL6/IFI16,3
Metabolism,Carbohydrate metabolism,hsa00500,Starch and sucrose metabolism,2/175,15/2914,0.13333333333333333,2.220190476190476,1.1974086835457909,0.2263914290544513,0.6045680207704097,0.49556975498761474,PYGL/ENPP1,2
Organismal Systems,Immune system,hsa04664,Fc epsilon RI signaling pathway,3/175,28/2914,0.10714285714285714,1.7840816326530613,1.0536233417271568,0.2346803994257631,0.6196617288208351,0.5079422010043129,RAC2/ALOX5AP/FCER1G,3
Organismal Systems,Endocrine system,hsa04920,Adipocytokine signaling pathway,3/175,29/2914,0.10344827586206896,1.7225615763546798,0.9883123084571614,0.25109899508527384,0.6556473760559928,0.5374399543930423,CD36/SOCS3/ACSL5,3
Metabolism,Lipid metabolism,hsa00061,Fatty acid biosynthesis,1/175,5/2914,0.2,3.3302857142857145,1.3180004690972527,0.2664713179700725,0.6800604722953394,0.5574515853529547,ACSL5,1
Organismal Systems,Endocrine system,hsa03320,PPAR signaling pathway,3/175,30/2914,0.1,1.6651428571428573,0.9254888300052235,0.267682419575977,0.6800604722953394,0.5574515853529547,CD36/ANGPTL4/ACSL5,3
Organismal Systems,Immune system,hsa04612,Antigen processing and presentation,2/175,17/2914,0.11764705882352941,1.9589915966386553,1.0022089232713915,0.27202418891813573,0.6800604722953394,0.5574515853529547,B2M/CD8B2,2
Organismal Systems,Digestive system,hsa04975,Fat digestion and absorption,2/175,17/2914,0.11764705882352941,1.9589915966386553,1.0022089232713915,0.27202418891813573,0.6800604722953394,0.5574515853529547,PLA2G5/CD36,2
Organismal Systems,Endocrine system,hsa04917,Prolactin signaling pathway,3/175,31/2914,0.0967741935483871,1.6114285714285714,0.8649629500944811,0.2843907044056234,0.6961647451595989,0.5706524002875997,CISH/IRF1/SOCS3,3
Human Diseases,Cancer: specific types,hsa05215,Prostate cancer,3/175,31/2914,0.0967741935483871,1.6114285714285714,0.8649629500944811,0.2843907044056234,0.6961647451595989,0.5706524002875997,IL1R2/CDK2/CDKN1A,3
Environmental Information Processing,Signal transduction,hsa04014,Ras signaling pathway,8/175,105/2914,0.0761904761904762,1.2686802721088435,0.7086761382461665,0.29382329096991977,0.7060835261363893,0.5787829128016092,FGF20/ANGPT2/VEGFA/PLA2G5/RAC2/FGF2/EPHA2/EFNA1,8
Metabolism,Metabolism of cofactors and vitamins,hsa00760,Nicotinate and nicotinamide metabolism,2/175,18/2914,0.1111111111111111,1.8501587301587301,0.9143874215435956,0.2948529439165304,0.7060835261363893,0.5787829128016092,NAMPT/ENPP1,2
Organismal Systems,Immune system,hsa04625,C-type lectin receptor signaling pathway,4/175,46/2914,0.08695652173913043,1.4479503105590061,0.773949162979434,0.29745646420213845,0.7060835261363893,0.5787829128016092,IRF1/IL1B/IL6/FCER1G,4
Human Diseases,Cancer: specific types,hsa05214,Glioma,3/175,32/2914,0.09375,1.5610714285714287,0.80656506091388,0.30118572115503806,0.7077864447143395,0.5801788102249682,GADD45B/GADD45A/CDKN1A,3
Genetic Information Processing,Transcription,hsa03020,RNA polymerase,1/175,6/2914,0.16666666666666666,2.775238095238095,1.1000901689210403,0.31059903173949055,0.7155958084194144,0.5865802147402144,POLR2J2,1
Human Diseases,Immune disease,hsa05310,Asthma,1/175,6/2914,0.16666666666666666,2.775238095238095,1.1000901689210403,0.31059903173949055,0.7155958084194144,0.5865802147402144,FCER1G,1
NA,NA,hsa04382,Cornified envelope formation,5/175,63/2914,0.07936507936507936,1.3215419501133787,0.6520825192484441,0.3269399737338291,0.7459310080334935,0.6114462462267832,TJP1/CLDN16/S100A8/S100A9/S100A3,5
Environmental Information Processing,Signal transduction,hsa04350,TGF-beta signaling pathway,4/175,49/2914,0.08163265306122448,1.3593002915451893,0.6410420919513474,0.3392185127756978,0.759203338117038,0.6223256926110547,HAMP/MYC/THBS1/INHBB,4
Human Diseases,Infectious disease: parasitic,hsa05142,Chagas disease,4/175,49/2914,0.08163265306122448,1.3593002915451893,0.6410420919513474,0.3392185127756978,0.759203338117038,0.6223256926110547,CCL2/IL1B/IL6/TLR2,4
Human Diseases,Drug resistance: antineoplastic,hsa01521,EGFR tyrosine kinase inhibitor resistance,3/175,35/2914,0.08571428571428572,1.427265306122449,0.6426937401136346,0.351738629266066,0.7797979045049577,0.6392072408708053,VEGFA/IL6/FGF2,3
Human Diseases,Neurodegenerative disease,hsa05020,Prion disease,6/175,81/2914,0.07407407407407407,1.2334391534391533,0.5385005761642095,0.35895292210535396,0.7883545485491419,0.6462211976908979,NCF2/IL1B/RAC2/IL6/TUBB6/CASP12,6
Human Diseases,Cancer: specific types,hsa05225,Hepatocellular carcinoma,5/175,66/2914,0.07575757575757576,1.2614718614718614,0.5430254504766598,0.3635387088914449,0.7910333017545329,0.6484169953911737,GADD45B/GADD45A/CDKN1A/MYC/WNT7A,5
Metabolism,Lipid metabolism,hsa00592,alpha-Linolenic acid metabolism,1/175,8/2914,0.125,2.0814285714285714,0.7740843345034844,0.3910904551917186,0.8355114270004896,0.6848761081347801,PLA2G5,1
Metabolism,Metabolism of cofactors and vitamins,hsa00770,Pantothenate and CoA biosynthesis,1/175,8/2914,0.125,2.0814285714285714,0.7740843345034844,0.3910904551917186,0.8355114270004896,0.6848761081347801,ENPP1,1
Cellular Processes,Cell motility,hsa04810,Regulation of actin cytoskeleton,7/175,101/2914,0.06930693069306931,1.1540594059405942,0.3982513807696326,0.40450558005193027,0.8499361174676993,0.6967001545199955,FGF20/MYLK2/CXCL12/RAC2/FGF2/LPAR4/ITGB3,7
Human Diseases,Infectious disease: viral,hsa05165,Human papillomavirus infection,10/175,149/2914,0.06711409395973154,1.1175455417066156,0.3722588048305646,0.40507593683566945,0.8499361174676993,0.6967001545199955,VEGFA/SPP1/CDK2/CDKN1A/IRF1/THBS1/WNT7A/TLR3/ISG15/ITGB3,10
Human Diseases,Immune disease,hsa05322,Systemic lupus erythematosus,4/175,55/2914,0.07272727272727272,1.2110129870129869,0.3992792148207238,0.42289295835895324,0.8665809970608286,0.710344109572818,FCGR2A/FCGR1A/FCGR3A/H4C2,4
Cellular Processes,Cellular community - eukaryotes,hsa04510,Focal adhesion,7/175,103/2914,0.06796116504854369,1.1316504854368932,0.34379844251646674,0.4247368221270472,0.8665809970608286,0.710344109572818,MYLK2/VEGFA/SPP1/RAC2/EMP1/THBS1/ITGB3,7
Metabolism,Carbohydrate metabolism,hsa00030,Pentose phosphate pathway,1/175,9/2914,0.1111111111111111,1.8501587301587301,0.645567198731983,0.42775913046406855,0.8665809970608286,0.710344109572818,TKTL2,1
Genetic Information Processing,Replication and repair,hsa03420,Nucleotide excision repair,1/175,9/2914,0.1111111111111111,1.8501587301587301,0.645567198731983,0.42775913046406855,0.8665809970608286,0.710344109572818,POLR2J2,1
Organismal Systems,Endocrine system,hsa04910,Insulin signaling pathway,4/175,56/2914,0.07142857142857142,1.1893877551020409,0.36166630402215294,0.4366594177991916,0.8721432130853517,0.7149035072547341,PYGL/TRIP10/PPP1R3B/SOCS3,4
Cellular Processes,Cell growth and death,hsa04216,Ferroptosis,2/175,25/2914,0.08,1.3321142857142858,0.4214800674537896,0.4484749952838426,0.8721432130853517,0.7149035072547341,SLC39A14/ACSL5,2
Human Diseases,Cancer: specific types,hsa05211,Renal cell carcinoma,2/175,25/2914,0.08,1.3321142857142858,0.4214800674537896,0.4484749952838426,0.8721432130853517,0.7149035072547341,VEGFA/CDKN1A,2
Human Diseases,Endocrine and metabolic disease,hsa04932,Non-alcoholic fatty liver disease,3/175,41/2914,0.07317073170731707,1.218397212543554,0.35592988719807417,0.45091001692107335,0.8721432130853517,0.7149035072547341,IL1B/IL6/SOCS3,3
Metabolism,Glycan biosynthesis and metabolism,hsa00532,Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,1/175,10/2914,0.1,1.6651428571428573,0.532488062605781,0.4622314720023778,0.8721432130853517,0.7149035072547341,CHSY1,1
Genetic Information Processing,Translation,hsa03008,Ribosome biogenesis in eukaryotes,1/175,10/2914,0.1,1.6651428571428573,0.532488062605781,0.4622314720023778,0.8721432130853517,0.7149035072547341,PWP2,1
Genetic Information Processing,"Folding, sorting and degradation",hsa04130,SNARE interactions in vesicular transport,1/175,10/2914,0.1,1.6651428571428573,0.532488062605781,0.4622314720023778,0.8721432130853517,0.7149035072547341,STX11,1
Human Diseases,Endocrine and metabolic disease,hsa04940,Type I diabetes mellitus,1/175,10/2914,0.1,1.6651428571428573,0.532488062605781,0.4622314720023778,0.8721432130853517,0.7149035072547341,IL1B,1
Environmental Information Processing,Signaling molecules and interaction,hsa04512,ECM-receptor interaction,4/175,58/2914,0.06896551724137931,1.148374384236453,0.28846098049742325,0.46390596440710197,0.8721432130853517,0.7149035072547341,SPP1/CD36/THBS1/ITGB3,4
Human Diseases,Cardiovascular disease,hsa05415,Diabetic cardiomyopathy,4/175,59/2914,0.06779661016949153,1.128910411622276,0.25281579012655636,0.47736048146830146,0.8903151836908797,0.7297992323199597,NCF2/RAC2/CD36/COL3A1,4
Cellular Processes,Cellular community - eukaryotes,hsa04540,Gap junction,3/175,43/2914,0.06976744186046512,1.1617275747508304,0.2700193926230071,0.4826850896734055,0.8931574493956717,0.7321290626625215,TJP1/HTR2B/TUBB6,3
Human Diseases,Cardiovascular disease,hsa05416,Viral myocarditis,2/175,27/2914,0.07407407407407407,1.2334391534391533,0.3079820747106122,0.48901271649988476,0.8941538897732701,0.7329458536551331,ICAM1/RAC2,2
Metabolism,Lipid metabolism,hsa00591,Linoleic acid metabolism,1/175,11/2914,0.09090909090909091,1.5137662337662339,0.431451152027165,0.49463832200223457,0.8941538897732701,0.7329458536551331,PLA2G5,1
Environmental Information Processing,Signal transduction,hsa04392,Hippo signaling pathway - multiple species,1/175,11/2914,0.09090909090909091,1.5137662337662339,0.431451152027165,0.49463832200223457,0.8941538897732701,0.7329458536551331,TEAD4,1
Human Diseases,Cancer: overview,hsa05207,Chemical carcinogenesis - receptor activation,5/175,78/2914,0.0641025641025641,1.0673992673992672,0.1524904389604683,0.5080326425444819,0.9113562671599484,0.7470467945812791,FGF20/VEGFA/BCL6/MYC/FGF2,5
Metabolism,Amino acid metabolism,hsa00340,Histidine metabolism,1/175,12/2914,0.08333333333333333,1.3876190476190475,0.3400480428932142,0.525102770383085,0.9278131657144735,0.7605366599137677,HDC,1
Organismal Systems,Environmental adaptation,hsa04710,Circadian rhythm,1/175,12/2914,0.08333333333333333,1.3876190476190475,0.3400480428932142,0.525102770383085,0.9278131657144735,0.7605366599137677,NFIL3,1
Environmental Information Processing,Signal transduction,hsa04370,VEGF signaling pathway,2/175,30/2914,0.06666666666666667,1.110095238095238,0.15318801367211318,0.546218219857482,0.9579200124366288,0.7852155085146835,VEGFA/RAC2,2
Environmental Information Processing,Signal transduction,hsa04310,Wnt signaling pathway,5/175,83/2914,0.060240963855421686,1.0030981067125644,0.007237002701577029,0.5646050473885983,0.9828310084171896,0.8056352722971813,RAC2/LGR6/MYC/WNT7A/VANGL1,5
Metabolism,Lipid metabolism,hsa00071,Fatty acid degradation,1/175,14/2914,0.07142857142857142,1.1893877551020409,0.17951889469258178,0.5806607746276466,0.9844493689305622,0.806961856726956,ACSL5,1
Genetic Information Processing,"Folding, sorting and degradation",hsa04120,Ubiquitin mediated proteolysis,2/175,32/2914,0.0625,1.0407142857142857,0.058528591307563584,0.581814594470885,0.9844493689305622,0.806961856726956,UBA7/SOCS3,2
Cellular Processes,Cellular community - eukaryotes,hsa04520,Adherens junction,2/175,32/2914,0.0625,1.0407142857142857,0.058528591307563584,0.581814594470885,0.9844493689305622,0.806961856726956,TJP1/RAC2,2
Human Diseases,Cancer: overview,hsa05203,Viral carcinogenesis,4/175,68/2914,0.058823529411764705,0.9794957983193276,-0.04323874936498644,0.5915335234734747,0.9844493689305622,0.806961856726956,JAK3/CDK2/CDKN1A/H4C2,4
Human Diseases,Cardiovascular disease,hsa05410,Hypertrophic cardiomyopathy,3/175,51/2914,0.058823529411764705,0.9794957983193276,-0.03733451633982255,0.5999634355641617,0.9844493689305622,0.806961856726956,EDN1/IL6/ITGB3,3
Environmental Information Processing,Signal transduction,hsa04072,Phospholipase D signaling pathway,4/175,69/2914,0.057971014492753624,0.9653002070393375,-0.07372309242794144,0.6033050221586944,0.9844493689305622,0.806961856726956,LPAR4/FCER1G/CXCR1/CXCR2,4
Organismal Systems,Endocrine system,hsa04926,Relaxin signaling pathway,4/175,69/2914,0.057971014492753624,0.9653002070393375,-0.07372309242794144,0.6033050221586944,0.9844493689305622,0.806961856726956,EDN1/ACTA2/VEGFA/COL3A1,4
Metabolism,Glycan biosynthesis and metabolism,hsa00512,Mucin type O-glycan biosynthesis,1/175,15/2914,0.06666666666666667,1.110095238095238,0.1080396845284838,0.605965727882875,0.9844493689305622,0.806961856726956,GALNT5,1
Genetic Information Processing,"Folding, sorting and degradation",hsa03018,RNA degradation,1/175,15/2914,0.06666666666666667,1.110095238095238,0.1080396845284838,0.605965727882875,0.9844493689305622,0.806961856726956,PARN,1
Human Diseases,Infectious disease: bacterial,hsa05131,Shigellosis,5/175,87/2914,0.05747126436781609,0.9569786535303776,-0.10296128907157881,0.6074262063614108,0.9844493689305622,0.806961856726956,IL1R1/IL1B/TIFA/CD14/CASP4,5
Human Diseases,Endocrine and metabolic disease,hsa04934,Cushing syndrome,4/175,70/2914,0.05714285714285714,0.9515102040816326,-0.1037833848196981,0.6148718972527736,0.9866112476645819,0.8087339678504749,NR4A1/CDK2/CDKN1A/WNT7A,4
Cellular Processes,Transport and catabolism,hsa04148,Efferocytosis,4/175,71/2914,0.056338028169014086,0.9381086519114687,-0.13343321106810924,0.6262300747138494,0.9866112476645819,0.8087339678504749,CD36/THBS1/CX3CR1/ITGB3,4
Metabolism,Glycan biosynthesis and metabolism,hsa00514,Other types of O-glycan biosynthesis,1/175,16/2914,0.0625,1.0407142857142857,0.04127155871225059,0.6297518602114353,0.9866112476645819,0.8087339678504749,GALNT5,1
Metabolism,Global and overview maps,hsa01212,Fatty acid metabolism,1/175,16/2914,0.0625,1.0407142857142857,0.04127155871225059,0.6297518602114353,0.9866112476645819,0.8087339678504749,ACSL5,1
NA,NA,hsa03272,Virion - Hepatitis viruses,1/175,16/2914,0.0625,1.0407142857142857,0.04127155871225059,0.6297518602114353,0.9866112476645819,0.8087339678504749,CLDN16,1
Organismal Systems,Immune system,hsa04658,Th1 and Th2 cell differentiation,2/175,36/2914,0.05555555555555555,0.9250793650793651,-0.1143142984185565,0.6467611512839913,0.9924796227261609,0.8135443268035272,IL4R/JAK3,2
Organismal Systems,Endocrine system,hsa04924,Renin secretion,2/175,36/2914,0.05555555555555555,0.9250793650793651,-0.1143142984185565,0.6467611512839913,0.9924796227261609,0.8135443268035272,EDN1/EDN3,2
Metabolism,Amino acid metabolism,hsa00310,Lysine degradation,1/175,17/2914,0.058823529411764705,0.9794957983193276,-0.02142823144744294,0.6521098396672665,0.9924796227261609,0.8135443268035272,PLOD2,1
NA,NA,hsa04981,Folate transport and metabolism,1/175,17/2914,0.058823529411764705,0.9794957983193276,-0.02142823144744294,0.6521098396672665,0.9924796227261609,0.8135443268035272,ABCG2,1
Environmental Information Processing,Signaling molecules and interaction,hsa04080,Neuroactive ligand-receptor interaction,11/175,198/2914,0.05555555555555555,0.9250793650793651,-0.2759703421612861,0.6546142192449146,0.9924796227261609,0.8135443268035272,EDN1/CALCA/EDN3/F2RL3/HTR2B/HCRTR2/GABRA6/LPAR4/ADM/FPR2/FPR1,11
Metabolism,Metabolism of cofactors and vitamins,hsa00670,One carbon pool by folate,1/175,18/2914,0.05555555555555555,0.9250793650793651,-0.0805808183287111,0.6731249511820157,0.9999813333778547,0.8196935453892382,MTHFD2,1
Human Diseases,Infectious disease: bacterial,hsa05110,Vibrio cholerae infection,1/175,18/2914,0.05555555555555555,0.9250793650793651,-0.0805808183287111,0.6731249511820157,0.9999813333778547,0.8196935453892382,TJP1,1
Cellular Processes,Transport and catabolism,hsa04144,Endocytosis,4/175,76/2914,0.05263157894736842,0.8763909774436089,-0.27595865740367204,0.6797857237807685,0.9999813333778547,0.8196935453892382,ARAP3/VPS28/CXCR1/CXCR2,4
Metabolism,Nucleotide metabolism,hsa00240,Pyrimidine metabolism,1/175,19/2914,0.05263157894736842,0.8763909774436089,-0.13661423017756272,0.6928774144220529,0.9999813333778547,0.8196935453892382,ENPP1,1
Organismal Systems,Sensory system,hsa04750,Inflammatory mediator regulation of TRP channels,3/175,59/2914,0.05084745762711865,0.8466828087167072,-0.3006817398725307,0.6985610113419811,0.9999813333778547,0.8196935453892382,IL1R1/IL1B/HTR2B,3
Organismal Systems,Development and regeneration,hsa04360,Axon guidance,5/175,97/2914,0.05154639175257732,0.858321060382916,-0.3586666462818191,0.7032294805360145,0.9999813333778547,0.8196935453892382,SEMA3G/CXCL12/RAC2/EPHA2/EFNA1,5
Metabolism,Lipid metabolism,hsa00564,Glycerophospholipid metabolism,2/175,40/2914,0.05,0.8325714285714286,-0.26946938796167896,0.7035100422578541,0.9999813333778547,0.8196935453892382,PLA2G5/LCAT,2
Organismal Systems,Endocrine system,hsa04914,Progesterone-mediated oocyte maturation,2/175,40/2914,0.05,0.8325714285714286,-0.26946938796167896,0.7035100422578541,0.9999813333778547,0.8196935453892382,CDK2/CCNB2,2
Organismal Systems,Digestive system,hsa04971,Gastric acid secretion,2/175,40/2914,0.05,0.8325714285714286,-0.26946938796167896,0.7035100422578541,0.9999813333778547,0.8196935453892382,MYLK2/KCNJ16,2
Organismal Systems,Digestive system,hsa04976,Bile secretion,2/175,40/2914,0.05,0.8325714285714286,-0.26946938796167896,0.7035100422578541,0.9999813333778547,0.8196935453892382,ABCG2/SLC4A5,2
Human Diseases,Endocrine and metabolic disease,hsa04930,Type II diabetes mellitus,1/175,20/2914,0.05,0.8325714285714286,-0.18988408082893574,0.7114426829803051,0.9999813333778547,0.8196935453892382,SOCS3,1
Human Diseases,Infectious disease: viral,hsa05170,Human immunodeficiency virus 1 infection,4/175,80/2914,0.05,0.8325714285714286,-0.38376723467694474,0.7186480439027825,0.9999813333778547,0.8196935453892382,RAC2/TLR2/CCNB2/B2M,4
Human Diseases,Endocrine and metabolic disease,hsa04936,Alcoholic liver disease,3/175,62/2914,0.04838709677419355,0.8057142857142857,-0.39080058310199456,0.7304711994271076,0.9999813333778547,0.8196935453892382,IL1B/IL6/CD14,3
Cellular Processes,Cell motility,hsa04820,Cytoskeleton in muscle cells,6/175,119/2914,0.05042016806722689,0.8395678271308523,-0.4516138898939106,0.7311819094133408,0.9999813333778547,0.8196935453892382,LMNB1/DSC2/THBS1/XIRP1/COL3A1/ITGB3,6
Cellular Processes,Cell growth and death,hsa04114,Oocyte meiosis,2/175,43/2914,0.046511627906976744,0.774485049833887,-0.37651841354251664,0.7409545913364312,0.9999813333778547,0.8196935453892382,CDK2/CCNB2,2
Organismal Systems,Endocrine system,hsa04922,Glucagon signaling pathway,2/175,43/2914,0.046511627906976744,0.774485049833887,-0.37651841354251664,0.7409545913364312,0.9999813333778547,0.8196935453892382,PYGL/LOC102724428,2
Metabolism,Lipid metabolism,hsa00565,Ether lipid metabolism,1/175,22/2914,0.045454545454545456,0.7568831168831169,-0.2892814368063724,0.7452912932072933,0.9999813333778547,0.8196935453892382,PLA2G5,1
Organismal Systems,Digestive system,hsa04973,Carbohydrate digestion and absorption,1/175,22/2914,0.045454545454545456,0.7568831168831169,-0.2892814368063724,0.7452912932072933,0.9999813333778547,0.8196935453892382,SLC2A5,1
Human Diseases,Neurodegenerative disease,hsa05010,Alzheimer disease,6/175,121/2914,0.049586776859504134,0.8256906729634003,-0.4949611294529203,0.7459381696620808,0.9999813333778547,0.8196935453892382,SLC39A14/IL1B/IL6/WNT7A/TUBB6/CASP12,6
Cellular Processes,Transport and catabolism,hsa04146,Peroxisome,1/175,23/2914,0.043478260869565216,0.7239751552795031,-0.3358777977159797,0.7607041644689543,0.9999813333778547,0.8196935453892382,ACSL5,1
Environmental Information Processing,Signal transduction,hsa04020,Calcium signaling pathway,7/175,142/2914,0.04929577464788732,0.8208450704225352,-0.5531839516340684,0.7616634548316719,0.9999813333778547,0.8196935453892382,FGF20/ITPKC/MYLK2/VEGFA/HTR2B/FGF2/MST1R,7
Organismal Systems,Immune system,hsa04660,T cell receptor signaling pathway,2/175,45/2914,0.044444444444444446,0.7400634920634921,-0.44412120910410774,0.7636254282609419,0.9999813333778547,0.8196935453892382,CARD11/CD8B2,2
Environmental Information Processing,Signal transduction,hsa04371,Apelin signaling pathway,3/175,66/2914,0.045454545454545456,0.7568831168831169,-0.5049057830922054,0.7688450113895936,0.9999813333778547,0.8196935453892382,MYLK2/ACTA2/SPP1,3
Environmental Information Processing,Signal transduction,hsa04012,ErbB signaling pathway,2/175,46/2914,0.043478260869565216,0.7239751552795031,-0.4769037826234892,0.7743060130039751,0.9999813333778547,0.8196935453892382,CDKN1A/MYC,2
Organismal Systems,Nervous system,hsa04727,GABAergic synapse,2/175,46/2914,0.043478260869565216,0.7239751552795031,-0.4769037826234892,0.7743060130039751,0.9999813333778547,0.8196935453892382,SLC38A5/GABRA6,2
Organismal Systems,Endocrine system,hsa04919,Thyroid hormone signaling pathway,2/175,46/2914,0.043478260869565216,0.7239751552795031,-0.4769037826234892,0.7743060130039751,0.9999813333778547,0.8196935453892382,MYC/ITGB3,2
Human Diseases,Cardiovascular disease,hsa05412,Arrhythmogenic right ventricular cardiomyopathy,2/175,47/2914,0.0425531914893617,0.7085714285714285,-0.5090500218652373,0.7845653659451948,0.9999813333778547,0.8196935453892382,DSC2/ITGB3,2
Human Diseases,Neurodegenerative disease,hsa05012,Parkinson disease,3/175,68/2914,0.04411764705882353,0.7346218487394958,-0.5596228298960145,0.7863107633463586,0.9999813333778547,0.8196935453892382,SLC39A14/TUBB6/UBA7,3
Organismal Systems,Immune system,hsa04622,RIG-I-like receptor signaling pathway,1/175,25/2914,0.04,0.6660571428571429,-0.42380067346867606,0.7888024840896519,0.9999813333778547,0.8196935453892382,ISG15,1
Metabolism,Lipid metabolism,hsa00561,Glycerolipid metabolism,1/175,26/2914,0.038461538461538464,0.6404395604395604,-0.4654287780358387,0.8015956877186968,0.9999813333778547,0.8196935453892382,LIPG,1
Metabolism,Lipid metabolism,hsa00590,Arachidonic acid metabolism,1/175,26/2914,0.038461538461538464,0.6404395604395604,-0.4654287780358387,0.8015956877186968,0.9999813333778547,0.8196935453892382,PLA2G5,1
Human Diseases,Substance dependence,hsa05033,Nicotine addiction,1/175,26/2914,0.038461538461538464,0.6404395604395604,-0.4654287780358387,0.8015956877186968,0.9999813333778547,0.8196935453892382,GABRA6,1
Environmental Information Processing,Signal transduction,hsa04390,Hippo signaling pathway,3/175,70/2914,0.04285714285714286,0.7136326530612245,-0.6129160167466342,0.8026780408533555,0.9999813333778547,0.8196935453892382,MYC/WNT7A/TEAD4,3
Organismal Systems,Digestive system,hsa04974,Protein digestion and absorption,2/175,50/2914,0.04,0.6660571428571429,-0.6019548312964694,0.812933914137859,0.9999813333778547,0.8196935453892382,SLC1A5/COL3A1,2
Human Diseases,Drug resistance: antineoplastic,hsa01524,Platinum drug resistance,1/175,27/2914,0.037037037037037035,0.6167195767195767,-0.5056713846789835,0.8136181096886512,0.9999813333778547,0.8196935453892382,CDKN1A,1
Environmental Information Processing,Membrane transport,hsa02010,ABC transporters,1/175,27/2914,0.037037037037037035,0.6167195767195767,-0.5056713846789835,0.8136181096886512,0.9999813333778547,0.8196935453892382,ABCG2,1
Metabolism,Global and overview maps,hsa01230,Biosynthesis of amino acids,1/175,28/2914,0.03571428571428571,0.5946938775510204,-0.5446371568636474,0.8249159381626678,0.9999813333778547,0.8196935453892382,TKTL2,1
Genetic Information Processing,"Folding, sorting and degradation",hsa04141,Protein processing in endoplasmic reticulum,1/175,28/2914,0.03571428571428571,0.5946938775510204,-0.5446371568636474,0.8249159381626678,0.9999813333778547,0.8196935453892382,CASP12,1
NA,NA,hsa04081,Hormone signaling,5/175,114/2914,0.043859649122807015,0.7303258145363408,-0.7423454246731176,0.8264541999349719,0.9999813333778547,0.8196935453892382,HAMP/CALCA/RAMP2/HCRTR2/ITGB3,5
Organismal Systems,Endocrine system,hsa04916,Melanogenesis,2/175,53/2914,0.03773584905660377,0.628355795148248,-0.6900802872008489,0.8379380021757636,0.9999813333778547,0.8196935453892382,EDN1/WNT7A,2
Human Diseases,Cancer: overview,hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,1/175,30/2914,0.03333333333333333,0.555047619047619,-0.6191128026609971,0.8455089668107759,0.9999813333778547,0.8196935453892382,TLR2,1
Environmental Information Processing,Signal transduction,hsa04071,Sphingolipid signaling pathway,2/175,54/2914,0.037037037037037035,0.6167195767195767,-0.7184950018466798,0.8455802778402849,0.9999813333778547,0.8196935453892382,RAC2/FCER1G,2
Metabolism,Carbohydrate metabolism,hsa00562,Inositol phosphate metabolism,1/175,33/2914,0.030303030303030304,0.5045887445887446,-0.7233432957104672,0.8719689451930864,0.9999813333778547,0.8196935453892382,ITPKC,1
Metabolism,Nucleotide metabolism,hsa00230,Purine metabolism,2/175,59/2914,0.03389830508474576,0.564455205811138,-0.8541792698716177,0.8791150185373209,0.9999813333778547,0.8196935453892382,ALLC/ENPP1,2
Metabolism,Global and overview maps,hsa01232,Nucleotide metabolism,1/175,34/2914,0.029411764705882353,0.4897478991596638,-0.7563473100481215,0.8797459096468212,0.9999813333778547,0.8196935453892382,ENPP1,1
Organismal Systems,Endocrine system,hsa04927,Cortisol synthesis and secretion,1/175,34/2914,0.029411764705882353,0.4897478991596638,-0.7563473100481215,0.8797459096468212,0.9999813333778547,0.8196935453892382,NR4A1,1
Cellular Processes,Cell motility,hsa04814,Motor proteins,3/175,82/2914,0.036585365853658534,0.609198606271777,-0.9072138172788388,0.8802504381661443,0.9999813333778547,0.8196935453892382,ACTA2/MYO1G/TUBB6,3
Organismal Systems,Sensory system,hsa04742,Taste transduction,1/175,35/2914,0.02857142857142857,0.4757551020408163,-0.7885707296541387,0.8870530158314762,0.9999813333778547,0.8196935453892382,GABRA6,1
Organismal Systems,Endocrine system,hsa04929,GnRH secretion,1/175,37/2914,0.02702702702702703,0.45003861003861007,-0.8508566206861583,0.9003689017433599,0.9999813333778547,0.8196935453892382,SPP1,1
Metabolism,Global and overview maps,hsa01200,Carbon metabolism,1/175,38/2914,0.02631578947368421,0.43819548872180447,-0.8809998414177682,0.906429187525394,0.9999813333778547,0.8196935453892382,TKTL2,1
Cellular Processes,Transport and catabolism,hsa04142,Lysosome,1/175,39/2914,0.02564102564102564,0.4269597069597069,-0.9105248221852684,0.91212282180323,0.9999813333778547,0.8196935453892382,SLC11A1,1
Environmental Information Processing,Signal transduction,hsa04152,AMPK signaling pathway,1/175,39/2914,0.02564102564102564,0.4269597069597069,-0.9105248221852684,0.91212282180323,0.9999813333778547,0.8196935453892382,CD36,1
Human Diseases,Cancer: overview,hsa05208,Chemical carcinogenesis - reactive oxygen species,2/175,66/2914,0.030303030303030304,0.5045887445887446,-1.0288713998766381,0.9149101805056277,0.9999813333778547,0.8196935453892382,VEGFA/NCF2,2
Metabolism,Global and overview maps,hsa01240,Biosynthesis of cofactors,1/175,42/2914,0.023809523809523808,0.3964625850340136,-0.9957031391672924,0.9272179207902789,0.9999813333778547,0.8196935453892382,MTHFD2,1
Human Diseases,Cancer: overview,hsa05231,Choline metabolism in cancer,1/175,43/2914,0.023255813953488372,0.3872425249169435,-1.0230562197080404,0.9316527619677515,0.9999813333778547,0.8196935453892382,RAC2,1
Environmental Information Processing,Signal transduction,hsa04024,cAMP signaling pathway,4/175,119/2914,0.03361344537815126,0.5597118847539015,-1.2394036984248027,0.9354554688411728,0.9999813333778547,0.8196935453892382,EDN1/ARAP3/EDN3/RAC2,4
Human Diseases,Drug resistance: antineoplastic,hsa01522,Endocrine resistance,1/175,44/2914,0.022727272727272728,0.37844155844155847,-1.049930639132831,0.9358188248920438,0.9999813333778547,0.8196935453892382,CDKN1A,1
Environmental Information Processing,Signal transduction,hsa04070,Phosphatidylinositol signaling system,1/175,44/2914,0.022727272727272728,0.37844155844155847,-1.049930639132831,0.9358188248920438,0.9999813333778547,0.8196935453892382,ITPKC,1
Human Diseases,Neurodegenerative disease,hsa05022,Pathways of neurodegeneration - multiple diseases,6/175,163/2914,0.03680981595092025,0.6129360210341805,-1.2853592116978836,0.9359979897848855,0.9999813333778547,0.8196935453892382,IL1B/IL6/WNT7A/TUBB6/UBA7/CASP12,6
Human Diseases,Infectious disease: parasitic,hsa05145,Toxoplasmosis,1/175,46/2914,0.021739130434782608,0.36198757763975153,-1.1023302554249508,0.9434084511385619,0.9999813333778547,0.8196935453892382,TLR2,1
Organismal Systems,Digestive system,hsa04972,Pancreatic secretion,1/175,47/2914,0.02127659574468085,0.35428571428571426,-1.1278951464857216,0.9468615616862438,0.9999813333778547,0.8196935453892382,PLA2G5,1
Organismal Systems,Endocrine system,hsa04928,"Parathyroid hormone synthesis, secretion and action",1/175,48/2914,0.020833333333333332,0.3469047619047619,-1.1530610269637338,0.9501051008229398,0.9999813333778547,0.8196935453892382,CDKN1A,1
Organismal Systems,Sensory system,hsa04740,Olfactory transduction,1/175,49/2914,0.02040816326530612,0.3398250728862973,-1.1778446226993113,0.953151718881553,0.9999813333778547,0.8196935453892382,OR51E1,1
Organismal Systems,Endocrine system,hsa04925,Aldosterone synthesis and secretion,1/175,51/2914,0.0196078431372549,0.3264985994397759,-1.2263266542004,0.9587010411334803,0.9999813333778547,0.8196935453892382,NR4A1,1
Organismal Systems,Endocrine system,hsa04921,Oxytocin signaling pathway,2/175,81/2914,0.024691358024691357,0.41114638447971774,-1.3583754334368863,0.9609771579485318,0.9999813333778547,0.8196935453892382,MYLK2/CDKN1A,2
Organismal Systems,Nervous system,hsa04722,Neurotrophin signaling pathway,1/175,52/2914,0.019230769230769232,0.3202197802197802,-1.250053587984029,0.9612254273722651,0.9999813333778547,0.8196935453892382,IRAK3,1
Human Diseases,Substance dependence,hsa05032,Morphine addiction,1/175,53/2914,0.018867924528301886,0.314177897574124,-1.2734553834884248,0.9635963393952749,0.9999813333778547,0.8196935453892382,GABRA6,1
Human Diseases,Cardiovascular disease,hsa05414,Dilated cardiomyopathy,1/175,54/2914,0.018518518518518517,0.30835978835978833,-1.2965442661705961,0.9658230575378218,0.9999813333778547,0.8196935453892382,ITGB3,1
Organismal Systems,Endocrine system,hsa04915,Estrogen signaling pathway,1/175,58/2914,0.017241379310344827,0.2870935960591133,-1.385991802708735,0.9734547511104559,0.9999813333778547,0.8196935453892382,FKBP5,1
Environmental Information Processing,Signal transduction,hsa04150,mTOR signaling pathway,1/175,61/2914,0.01639344262295082,0.27297423887587824,-1.4502974452452655,0.9780430082439713,0.9999813333778547,0.8196935453892382,WNT7A,1
Organismal Systems,Environmental adaptation,hsa04714,Thermogenesis,1/175,61/2914,0.01639344262295082,0.27297423887587824,-1.4502974452452655,0.9780430082439713,0.9999813333778547,0.8196935453892382,ACSL5,1
Organismal Systems,Endocrine system,hsa04935,"Growth hormone synthesis, secretion and action",1/175,61/2914,0.01639344262295082,0.27297423887587824,-1.4502974452452655,0.9780430082439713,0.9999813333778547,0.8196935453892382,SOCS3,1
Organismal Systems,Nervous system,hsa04726,Serotonergic synapse,1/175,64/2914,0.015625,0.2601785714285714,-1.5124732899240556,0.9818419427252747,0.9999813333778547,0.8196935453892382,HTR2B,1
Human Diseases,Neurodegenerative disease,hsa05014,Amyotrophic lateral sclerosis,2/175,96/2914,0.020833333333333332,0.3469047619047619,-1.6445038322382504,0.982624528950979,0.9999813333778547,0.8196935453892382,TUBB6/CASP12,2
Human Diseases,Neurodegenerative disease,hsa05016,Huntington disease,2/175,96/2914,0.020833333333333332,0.3469047619047619,-1.6445038322382504,0.982624528950979,0.9999813333778547,0.8196935453892382,TUBB6/POLR2J2,2
Organismal Systems,Nervous system,hsa04723,Retrograde endocannabinoid signaling,1/175,70/2914,0.014285714285714285,0.23787755102040814,-1.6311812806005064,0.9875893878060413,0.9999813333778547,0.8196935453892382,GABRA6,1
Human Diseases,Substance dependence,hsa05034,Alcoholism,1/175,86/2914,0.011627906976744186,0.19362126245847175,-1.9184118192771138,0.9955198672742138,0.9999813333778547,0.8196935453892382,H4C2,1
Environmental Information Processing,Signal transduction,hsa04022,cGMP-PKG signaling pathway,1/175,88/2914,0.011363636363636364,0.18922077922077923,-1.951871027141204,0.9960572754557804,0.9999813333778547,0.8196935453892382,MYLK2,1
NA,NA,hsa04082,Neuroactive ligand signaling,2/175,124/2914,0.016129032258064516,0.26857142857142857,-2.103652072039341,0.9963846000667276,0.9999813333778547,0.8196935453892382,HTR2B/GABRA6,2
Metabolism,Global and overview maps,hsa01100,Metabolic pathways,14/175,537/2914,0.0260707635009311,0.4341154562383613,-3.6693879847452995,0.9999813333778547,0.9999813333778547,0.8196935453892382,MTHFD2/ITPKC/PYGL/LIPG/NAMPT/PLA2G5/CHSY1/GALNT5/HDC/TKTL2/ALLC/PLOD2/ACSL5/ENPP1,14
